How to buy Immix Biopharma stock in Canada

Immix Biopharma is a biotechnology business based in the US. Immix Biopharma shares (IMMX) are listed on the NASDAQ and all prices are listed in US Dollars.

Its last market close was $1.63 – a decrease of 1.21% over the previous week. Immix Biopharma employs 14 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Immix Biopharma stock

Buy Immix Biopharma stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

Immix Biopharma stock price (NASDAQ: IMMX)

Use our graph to track the performance of IMMX stocks over time.

Immix Biopharma stocks at a glance

• Key figures

Information last updated 2025-03-06.

Latest market close	$1.63
52-week range	$1.26 - $3.35
50-day moving average more info button	$2.00
200-day moving average more info button	$1.96
Wall St. target price	$7.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.84

Is it a good time to buy Immix Biopharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Immix Biopharma price performance over time

Historical closes compared with the close of $1.64 from 2025-03-11

1 week (2025-03-06)	-0.61%
1 month (2025-02-13)	-17.59%
3 months (2024-12-13)	-19.61%
6 months (2024-09-13)	-11.83%

1 year (2024-03-13)	-46.75%
2 years (2023-03-13)	-20.39%
3 years (2022-03-11)	1.86
5 years (2020-03-09)	N/A

Immix Biopharma financials

Gross profit TTM	$0
Return on assets TTM	-60.55%
Return on equity TTM	-118.5%
Profit margin	0%
Book value	$0.64
Market Capitalization more info button	$45.4 million

TTM: trailing 12 months

Immix Biopharma stock dividends

We're not expecting Immix Biopharma to pay a dividend over the next 12 months.

Immix Biopharma stock price volatility

Over the last 12 months, Immix Biopharma's stocks have ranged in value from as little as $1.26 up to $3.3528. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Immix Biopharma's is 0.253. This would suggest that Immix Biopharma's stocks are less volatile than average (for this exchange).

Immix Biopharma overview

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and immune-dysregulated diseases in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and colorectal cancer; and NXC-201 for relapsed/refractory multiple myeloma. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of Immix Biopharma is owned by insiders or institutions?
Currently 40.098% of Immix Biopharma stocks are held by insiders and 12.157% by institutions. How many people work for Immix Biopharma?
Latest data suggests 14 work at Immix Biopharma. When does the fiscal year end for Immix Biopharma?
Immix Biopharma's fiscal year ends in December. Where is Immix Biopharma based?
Immix Biopharma's address is: 11400 West Olympic Boulevard, Los Angeles, CA, United States, 90064 What is Immix Biopharma's ISIN number?
Immix Biopharma's international securities identification number is: US45258H1068 What is Immix Biopharma's CUSIP number?
Immix Biopharma's Committee on Uniform Securities Identification Procedures number is: 45258H106

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.